Second-look laparotomy for stage III epithelial ovarian cancer: rationale and current issues
- 1 November 1995
- journal article
- review article
- Published by Elsevier in Cancer Treatment Reviews
- Vol. 21 (6) , 499-511
- https://doi.org/10.1016/0305-7372(95)90014-4
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Experience with Positron Emission Tomography (PET) Scans in Patients with Ovarian CancerGynecologic Oncology, 1994
- Whole-Body Positron Emission Tomography with 2-[18F]-Fluoro-2-deoxy-D-glucose Can Detect Recurrent Ovarian CarcinomaGynecologic Oncology, 1993
- Assessment of Primary and Metastatic Ovarian Cancer by Positron Emission Tomography (PET) Using 2-[18F]Deoxyglucose (2-[18F]FDG)Gynecologic Oncology, 1993
- Intraperitoneal Carboplatin and Etoposide for Persistent Epithelial Ovarian Cancer: Analysis of Results by Prior Sensitivity to Platinum-Based RegimensGynecologic Oncology, 1993
- Second-look versus second-natureGynecologic Oncology, 1992
- Long-term survival in ovarian cancerEuropean Journal of Cancer and Clinical Oncology, 1991
- Second Thoughts about Second-Look Laparotomy in Advanced Ovarian CancerNew England Journal of Medicine, 1990
- CA125 Serum Levels and Secondary Laparotomy in Epithelial Ovarian TumoursAustralian and New Zealand Journal of Obstetrics and Gynaecology, 1987
- AnnouncementGynecologic Oncology, 1986
- CA 125 Serum Levels Correlated With Second-Look Operations Among Ovarian Cancer PatientsObstetrics & Gynecology, 1986